• Nenhum resultado encontrado

Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.

N/A
N/A
Protected

Academic year: 2017

Share "Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice."

Copied!
9
0
0

Texto

Loading

Referências

Documentos relacionados

In terms of T cell responses, we observed an early robust response to NS3 and NS4 (mostly CD4; data not shown), which was maintained at a lower level during chronic disease,

A survey was conducted in the hemodialysis population of the state of Tocantins, Brazil, aiming to assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus

In order to estimate the prevalence of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) co-infection in hard-to-reach intravenous drug users, 199 subjects

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

We investigated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) serological markers of infection in young adults from the metropolitan region of Florianópolis

Parts of 5’ non-coding (5’ NC) and of E1 envelope regions of the hepatitis C virus (HCV) genome were amplified from sera of 26 Brazilian anti-HCV antibody-positive patients using

The objective of the present cross-sectional study was to assess the prevalence and the clinical and laboratory features of hepatitis C virus (HCV)-positive patients with type

The potential impact of the hepatitis C virus (HCV) on clinical, immunological and virological responses to initial highly active antiretroviral therapy (HAART) of patients